Literature DB >> 30945679

LINC24065 is a monoallelically expressed long intergenic noncoding RNA located in the cattle DLK1-DIO3 cluster.

Cui Zhang1, Da Xu, Weina Chen, Junliang Li, Qinghua Gao, Shijie Li.   

Abstract

Long noncoding RNAs (lncRNAs) are important regulators of biological processes, and regulate genomic imprinting in cis and/or trans to induce monoallelic expression with parent-origin-specific pattern. DLK1-DIO3 domain is one of the largest imprinted clusters in mammals, and maternally expressed noncoding RNAs of this region is related to the pluripotency of the embryonic stem cells. Previously, we sequenced the cDNA of two maternally expressed noncoding RNAs, MEG8 and MEG9, and mapped a lncRNA (LINC24061) between the two genes in the cattle DLK1-DIO3 domain on chromosome 21. In this study, we identified LINC24065, a novel long intergenic noncoding RNA (lincRNA), which was also located between MEG8 and MEG9. We identified four variants of LINC24065 (LINC24065-v1, LINC24065-v2, LINC24065-v3 and LINC24065-v4) that were a result of alternative splicing from 18 exons. LINC24065-v1 and LINC24065-v2 showed tissue-specific expression patterns in adultbovine tissues, and LINC24065-v3 and LINC24065-v4 were detected in all eight analysed tissues (heart, liver, spleen, lung, kidney, skeletal muscle, adipose and brain). Using single-nucleotide polymorphism (SNP)-based method, LINC24065 was identified to have monoallelic expression in adult tissues, suggesting that it is imprinted in cows. These results provide a foundation for further investigation about whether LINC24065 plays a role in regulating imprinting of the DLK1-DIO3 domain.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30945679

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  10 in total

Review 1.  Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.

Authors:  Dominique Simon; Juliane Léger; Jean-Claude Carel
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-06       Impact factor: 4.690

Review 2.  Genetic Mutations, Birth Lengths, Weights and Head Circumferences of Children with IGF-I Receptor Defects. Comparison with other Congenital Defects in the GH/IGF-I axis.

Authors:  Jenna Lee Essakow; Aharon Lauterpacht; Pearl Lilos; Rivka Kauli; Zvi Laron
Journal:  Pediatr Endocrinol Rev       Date:  2016-09

3.  Three novel IGF1R mutations in microcephalic patients with prenatal and postnatal growth impairment.

Authors:  Matias Juanes; Gabriela Guercio; Roxana Marino; Esperanza Berensztein; Diana Mónica Warman; Marta Ciaccio; Silvia Gil; Marcela Bailez; Marco A Rivarola; Alicia Belgorosky
Journal:  Clin Endocrinol (Oxf)       Date:  2014-08-07       Impact factor: 3.478

4.  Heterozygous nonsense mutations near the C-terminal region of IGF1R in two patients with small-for-gestational-age-related short stature.

Authors:  Masanobu Fujimoto; Yuki Kawashima Sonoyama; Naoki Hamajima; Takashi Hamajima; Yumiko Kumura; Naoki Miyahara; Rei Nishimura; Kaori Adachi; Eiji Nanba; Keiichi Hanaki; Susumu Kanzaki
Journal:  Clin Endocrinol (Oxf)       Date:  2015-05-11       Impact factor: 3.478

Review 5.  IGF1R mutations as cause of SGA.

Authors:  J Klammt; W Kiess; R Pfäffle
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-02       Impact factor: 4.690

6.  Expanding Genetic and Functional Diagnoses of IGF1R Haploinsufficiencies.

Authors:  Paula Ocaranza; Marjorie C Golekoh; Shayne F Andrew; Michael H Guo; Paul Kaplowitz; Howard Saal; Ron G Rosenfeld; Andrew Dauber; Fernando Cassorla; Philippe F Backeljauw; Vivian Hwa
Journal:  Horm Res Paediatr       Date:  2017-04-10       Impact factor: 2.852

7.  Familial short stature is associated with a novel dominant-negative heterozygous insulin-like growth factor 1 receptor (IGF1R) mutation.

Authors:  Yuki Kawashima; Fumihiko Hakuno; Shin-ichi Okada; Tomoyuki Hotsubo; Tomoe Kinoshita; Masanobu Fujimoto; Rei Nishimura; Toshiaki Fukushima; Keiichi Hanaki; Shin-ichiro Takahashi; Susumu Kanzaki
Journal:  Clin Endocrinol (Oxf)       Date:  2013-09-30       Impact factor: 3.478

8.  Association of insulin growth factor-1 receptor gene polymorphisms with genetic susceptibility to idiopathic short stature.

Authors:  Y Yang; H Huang; W Wang; L Yang; L L Xie; W Huang
Journal:  Genet Mol Res       Date:  2013-10-18

9.  Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation.

Authors:  Eva Müller; Desiree Dunstheimer; Jürgen Klammt; Daniela Friebe; Wieland Kiess; Jürgen Kratzsch; Tassilo Kruis; Sandy Laue; Roland Pfäffle; Tillmann Wallborn; Peter H Heidemann
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Response to Growth Hormone Treatment in a Patient with Insulin-Like Growth Factor 1 Receptor Deletion.

Authors:  Ranim Mahmoud; Ajanta Naidu; Hiba Risheg; Virginia Kimonis
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-07-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.